{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:11:28Z","timestamp":1783635088959,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1992,10,1]],"date-time":"1992-10-01T00:00:00Z","timestamp":717897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1992,10]]},"DOI":"10.1007\/bf03345807","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T14:51:56Z","timestamp":1395413516000},"page":"631-642","source":"Crossref","is-referenced-by-count":115,"title":["Malignant pheochromocytoma: Clinical, biological, histologic and therapeutic data in a series of 20 patients with distant metastases"],"prefix":"10.1007","volume":"15","author":[{"given":"M.","family":"Schlumberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gicquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lumbroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tenenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Comoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bosq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. P.","family":"Ghillani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Travagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gardet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Parmentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,22]]},"reference":[{"key":"BF03345807_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0022-5347(17)57951-3","volume":"118","author":"EM Mahoney","year":"1977","unstructured":"Mahoney E.M., Harrison J.H. Malignant pheochromocytoma: clinical course and treatment. J. Urol. 118: 225, 1977.","journal-title":"J. Urol."},{"key":"BF03345807_CR2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1464-410X.1985.tb06295.x","volume":"57","author":"HJE Lewi","year":"1985","unstructured":"Lewi H.J.E., Reid R., Mucci B., Davidson J.K., Kyle K.F., Mc Pherson S.G., Semple P., Kaye S. Malignant pheochromocytoma. Br. J. Urol. 57: 394, 1985.","journal-title":"Br. J. Urol."},{"key":"BF03345807_CR3","first-page":"367","volume":"91","author":"JA Herdeen Van","year":"1982","unstructured":"Van Herdeen J.A., Sheps S.G., Hamberger B., Sheedy P.F., Poston J.G., Remine W.H. Pheochromocytoma: current status and changing trends. Surgery 91: 367, 1982.","journal-title":"Surgery"},{"key":"BF03345807_CR4","first-page":"869","volume":"10","author":"PF Plouin","year":"1981","unstructured":"Plouin P.F., Degoulet P., Tugaye A., Ducrocq M.B., Menard J. Le d\u00e9pistage du ph\u00e9ochromocytome chez quels hypertendus? Etude s\u00e9miologique chez 2585 hypertendus dont 11 ayant un ph\u00e9ochromocytome. Nouv. Press. M\u00e9d. 10: 869, 1981.","journal-title":"Nouv. Press. M\u00e9d."},{"key":"BF03345807_CR5","first-page":"139","volume":"58","author":"WM Manger","year":"1982","unstructured":"Manger W.M., Gifford R.W. Hypertension secondary to pheochromocytoma. Bull. N.Y. Acad. Med. 58: 139, 1982.","journal-title":"Bull. N.Y. Acad. Med."},{"key":"BF03345807_CR6","first-page":"801","volume":"154","author":"WH Scott","year":"1982","unstructured":"Scott W.H., Reynolds V., Green N., Page D., Oates J.A., Robertson D., Roberts S. Clinical experience with malignant phaeochromocytoma. Surg. Gyn. Obs. 154: 801, 1982.","journal-title":"Surg. Gyn. Obs."},{"key":"BF03345807_CR7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.1984.tb00074.x","volume":"20","author":"B Shapiro","year":"1984","unstructured":"Shapiro B., Sisson J.C., Lloyd R., Nakajo M., Satterlee W., Beierwaltes W.H. Malignant phaeochromocytoma: clinical, biochemical and scintigraphic characterization. Clin. Endocrinol. (Oxf.) 20: 189, 1984.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03345807_CR8","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/1097-0142(19881201)62:11<2451::AID-CNCR2820621134>3.0.CO;2-Q","volume":"62","author":"NA Samaan","year":"1988","unstructured":"Samaan N.A., Hickey R.C., Shutts P.E. Diagnosis, localization and management of pheochromocytoma. Cancer 62: 2451, 1988.","journal-title":"Cancer"},{"key":"BF03345807_CR9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/mpo.2950150405","volume":"15","author":"WH Beierwaltes","year":"1987","unstructured":"Beierwaltes W.H. Update on basic research and clinical experience with metaiodobenzylguanidine. Med. Ped. Oncol. 15: 163, 1987.","journal-title":"Med. Ped. Oncol."},{"key":"BF03345807_CR10","first-page":"576","volume":"26","author":"B Shapiro","year":"1985","unstructured":"Shapiro B., Copp J.E., Sisson J.C., Eyre P.L., Wallis J., Beierwaltes W.H. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J. Nucl. Med. 26: 576, 1985.","journal-title":"J. Nucl. Med."},{"key":"BF03345807_CR11","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/bmj.288.6430.1587","volume":"288","author":"DM Ackery","year":"1984","unstructured":"Ackery D.M., Tippett P.A., Condon B.R., Sutton H.E., Wyeth P. New approach to the localisation of phaeochromocytoma: imaging with iodine-131-metaiodobenzyl-guanidine. Br. Med. J. 288: 1587, 1984.","journal-title":"Br. Med. J."},{"key":"BF03345807_CR12","first-page":"445","volume-title":"Diagnostic Surgical Pathology","author":"RA DeLellis","year":"1988","unstructured":"DeLellis R.A. The adrenal glands. In: Sternberg S.S. (Ed), Diagnostic Surgical Pathology. Raven Press, New York, 1988, p. 445."},{"key":"BF03345807_CR13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/bmj.282.6267.853","volume":"282","author":"PF Plouin","year":"1981","unstructured":"Plouin P.F., Duclos J.M., Menard J., Comoy E., Bohuon C., Alexandre J.M. Biochemical tests for diagnosis of phaeochromocytoma: urinary versus plasma determinations. Br. Med. J. 282: 853, 1981.","journal-title":"Br. Med. J."},{"key":"BF03345807_CR14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1210\/jcem-68-4-808","volume":"64","author":"E Grouzmann","year":"1989","unstructured":"Grouzmann E., Comoy E., Bohuon C. Plasma neuropeptide Y concentrations in patients with neuroendocrine tumors. J. Clin. Endocrinol. Metab. 64: 808, 1989.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345807_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0009-8981(88)90365-8","volume":"174","author":"P Motte","year":"1988","unstructured":"Motte P., Vauzelle P., Gardet P., Ghillani P., Caillou B., Parmentier C., Bohuon C., Bellet D. Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies. Clin. Chim. Acta 174: 35, 1988.","journal-title":"Clin. Chim. Acta"},{"key":"BF03345807_CR16","first-page":"6845","volume":"49","author":"PP Ghillani","year":"1989","unstructured":"Ghillani P.P., Motte P., Troalen F., Jullienne A., Gardet P., Le Chevalier T., Rougier P., Schlumberger M., Bohuon C., Bellet D. Identification and measurement of calcitonin precursors in serum of patients with malignant disease. Cancer Res. 49: 6845, 1989.","journal-title":"Cancer Res."},{"key":"BF03345807_CR17","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0140-6736(81)92682-9","volume":"1","author":"FJ Tapia","year":"1981","unstructured":"Tapia F.J., Polak J.M., Barbosa A.J.A., Bloom S.R., Marangos P.J., Dermody C., Pearse A.G.E. Neuron-specific enolase is produced by neuroen docrine tumors. Lancet 1: 808, 1981.","journal-title":"Lancet"},{"key":"BF03345807_CR18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jcem-57-1-148","volume":"57","author":"M Schlumberger","year":"1983","unstructured":"Schlumberger M., Charbord P., Fragu P., Gardet P., Lumbroso J., Parmentier C., Tubiana M. Relationship between TSH stimulation and radioio-dine uptake in lung metastases of differentiated thy roid carcinoma. J. Clin. Endocrinol. Metab. 57: 148, 1983.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345807_CR19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1210\/jcem-72-2-455","volume":"72","author":"H Krempf","year":"1991","unstructured":"Krempf H., Lumbroso J., Mornex R., Brendel A.J., Wemeau J.L., Delisle HJ., Aubert B., Carpentier P., Fleury-Goyon M.C., Gibold C., Guyot M., Lanheche B., Marchandise X., Schlumberger M., Charbonnel B., Chatal J.F. Use of 131l m-lodobenzylguanidine (131I-MIBG) in the treatment of malignant pheochromocytoma. J. Clin. Endocrinol. Metab. 72: 445, 1991.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345807_CR20","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198112313052704","volume":"305","author":"VM Riccardi","year":"1981","unstructured":"Riccardi V.M. Von Recklinghausen neurofibromatosis. N. Engl. J. Med. 305: 1617, 1981.","journal-title":"N. Engl. J. Med."},{"key":"BF03345807_CR21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.1976.03630070017007","volume":"136","author":"WA Horton","year":"1976","unstructured":"Horton W.A., Wong V., Eldrich R. Von Hippel-Lindau disease. Arch. Intern. Med. 136: 769, 1976.","journal-title":"Arch. Intern. Med."},{"key":"BF03345807_CR22","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1210\/jcem-64-6-1199","volume":"64","author":"JM Allen","year":"1987","unstructured":"Allen J.M., Yeats J.C., Causon R., Brown M.J., Bloom S.R. Neuropeptide Y and its flanking peptide in human endocrine tumors and plasma. J. Clin. Endocrinol. Metab. 64: 1199, 1987.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345807_CR23","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/1097-0142(19901015)66:8<1833::AID-CNCR2820660831>3.0.CO;2-9","volume":"66","author":"E Grouzmann","year":"1990","unstructured":"Grouzmann E., Gicquel C., Plouin P.F., Schlumberger M., Comoy E., Bohuon C. Neuropeptide Y and Neuron Specific Enolase levels in benign and malignant pheochromocytomas. Cancer 66: 1833, 1990.","journal-title":"Cancer"},{"key":"BF03345807_CR24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/1097-0142(19880315)61:6<1167::AID-CNCR2820610618>3.0.CO;2-U","volume":"61","author":"S Oishi","year":"1988","unstructured":"Oishi S., Tatsuo S. Elevated serum neuron-specific enolase in patients with malignant phaeochromocytoma. Cancer 61: 1167, 1988.","journal-title":"Cancer"},{"key":"BF03345807_CR25","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1210\/jcem-63-4-960","volume":"63","author":"M Schlumberger","year":"1986","unstructured":"Schlumberger M., Tubiana M., De Vathaire F., C., Gardet P., Travagli J.P., Fragu P., Lumbroso J., Caillou B., Parmentier C. Long-term results of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 63: 960, 1986.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03345807_CR26","first-page":"197","volume":"24","author":"JC Sisson","year":"1984","unstructured":"Sisson J.C., Shapiro B., Beierwaltes W.H., Glonniak J.V., Nakajo M., Mangner T.J., Carey J.E., Swanson DP., Copp J.E., Satterlee W.G., Wieland D.M. Radiopharmaceutical treatment of malignant pheochromocytoma. J. Nucl. Med. 24: 197, 1984.","journal-title":"J. Nucl. Med."},{"key":"BF03345807_CR27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.7326\/0003-4819-109-4-267","volume":"109","author":"SD Averbuch","year":"1988","unstructured":"Averbuch S.D., Steakley CS., Young R.C., Gelmann E.P., Goldstein D.S., Stull R., Keiser H.R. Malignant pheochromocytoma: effective treatment with a combination of Cyclophosphamide, Vincristine and Dacarbazine. Ann. Intern. Med. 109: 267, 1988.","journal-title":"Ann. Intern. Med."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345807.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03345807\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T15:50:29Z","timestamp":1565279429000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03345807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,10]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1992,10]]}},"alternative-id":["BF03345807"],"URL":"https:\/\/doi.org\/10.1007\/bf03345807","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,10]]}}}